Northwest Biotherapeutics reported 36.72M in Trade Creditors for its fiscal quarter ending in September of 2025.





Trade Creditors Change Date
Agenus USD 71.08M 11.9M Mar/2026
AstraZeneca USD 22.51B 2.78B Mar/2026
Bristol-Myers Squibb USD 4.23B 659M Mar/2026
Celldex Therapeutics USD 10.36M 9.18M Mar/2026
Eisai JPY 75.89B 9.6B Mar/2026
Infinity Pharmaceuticals USD 1.5M 433K Jun/2023
Merck USD 3.86B 541M Mar/2026
Northwest Biotherapeutics 36.72M 9.49M Sep/2025
Pfizer USD 4.51B 734M Mar/2026
Plus Therapeutics 5.92M 5.7M Dec/2025
Roche Holding CHF 5.78B 1.27B Dec/2025